We build large datasets of anonymised patient data in collaboration with the NHS, providing a rich source of clinical information while protecting patient privacy.
We curate and analyse the datasets using AI algorithms.
We identify patterns using proprietary machine learning and deep learning technologies.
We discover new insights of significant value to patients, clinicians and the life science industry.
The Translational Medicine Team at Sensyne Health combines clinical and data science expertise to develop machine learning technologies applied to ethically sourced anonymised electronic patient record (EPR) data received from our unique partnership with the NHS.
We use EPR information to create large longitudinal datasets, then develop clinically driven AI technology that analyses and contextualises that information identifying previously unseen patterns and insights that can be used to undertake advanced medical research, improve pharmaceutical development and deliver better patient care.
The current medical discovery system involves interpreting enormous volumes of diverse information. It can be like finding a needle in a haystack, without knowing what a needle is, what a needle looks like or where the haystack is. We aim to change that.
Learn more about our NHS partnership approach
Learn more about our Life Sciences approach
Find our latest news
Join the Discovery Team
Using real-world data has a real-world impact. We use it to:
Improve clinical trials by distinguishing specific groups of patients and Identifying sub-sets of responders and non-responders.
Understand the mechanism of disease in the real world in order to personalise treatment and coherently diagnose sufferers of poorly understood diseases.
Predict clinical events earlier such as Stroke or heart failure.
Discover new treatments faster to address unmet medical needs.
Information based on RWE can provide vital indicators to better prevent, treat and understand the cause and progression of disease. It enables a level of insight and analysis simply not possible to achieve from other research datasets. It is richer, more extensive and more representative of large patient populations.
Traditionally, medicinal research starts in the lab. We take a different approach. From ‘bedside to bench’ deconstructing the classical R&D pipeline model by putting patient data and patient outcomes at the beginning of the drug discovery and development process.
© 2019 Sensyne Health plc. All rights reserved.
Sensyne Health Group Limited. registered in England and Wales No. 11240986 is a trading company of Sensyne Health plc registered in England and Wales No. 11425451
Registered office: Schrödinger Building, Heatley Road, Oxford Science Park, Oxford, OX4 4GE, United Kingdom.
Note: Not all Sensyne Health products are available in all geographies, for further information contact head office.
